Regulation of oxidative stress responses by ataxia-telangiectasia mutated is required for T cell proliferation

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 4757-4763

  Bagley, Jessamyn ^a   Singh, Gyanesh ^a   Iacomini, John ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 34247139378     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.4757     Document Type: Article

References (40)

1. Shiloh, Y. 2001. ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochem. Soc. Trans. 29: 661-666.
2. Lavin, M. F., and Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15: 177-202.
3. + T cell subsets in ataxia telangiectasia. Clin. Exp. Immunol. 129: 125-132.
4. Nowak-Wegrzyn, A., T. O. Crawford, J. A. Winkelstein, K. A. Carson, and H. M. Lederman. 2004. Immunodeficiency and infections in ataxia-telangiectasia. J. Pediatr. 144: 505-511.
5. Datta, U., S. Sehgal, L. Kumar, K. J. Kaur, B. N. Walia, J. S. Chopra, and R. K. Marwaha. 1991. Immune status in ataxia telangiectasia. Indian J. Med. Res. 94: 252-254.
6. Giovannetti, A., F. Mazzetta, E. Caprini, A. Aiuti, M. Marziali, M. Pierdominici, A. Cossarizza, L. Chessa, E. Scala, I. Quinti, et al. 2002. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood 100: 4082-4089.
7. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J. N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159-171.
8. Borghesani, P. R., F. W. Alt, A. Bottaro, L. Davidson, S. Aksoy, G. A. Rathbun, T. M. Roberts, W. Swat, R. A. Segal, and Y. Gu. 2000. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc. Natl. Acad. Sci. USA 97: 3336-3341.
9. Bagley, J., M. L. Cortes, X. O. Breakefield, and J. Iacomini. 2004. Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice. Blood 104: 572-578.
10. Rotman, G., and Y. Shiloh. 1997. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? BioEssays 19: 911-917.
11. Ito, K., A. Hirao, F. Arai, S. Matsuoka, K. Takubo, I. Hamaguchi, K. Nomiyama, K. Hosokawa, K. Sakurada, N. Nakagata, et al. 2004. Regulation of oxidative stress by ATM is required for self-renewal of hematopoietic stem cells. Nature 431: 997-1002.
12. Schubert, R., L. Erker, C. Barlow, H. Yakushiji, D. Larson, A. Russo, J. B. Mitchell, and A. Wynshaw-Boris. 2004. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet. 13: 1793-1802.
13. Barlow, C., P. A. Dennery, M. K. Shigenaga, M. A. Smith, J. D. Morrow, L. J. Roberts II, A. Wynshaw-Boris, and R. L. Levine. 1999. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 96: 9915-9919.
14. Devadas, S., L. Zaritskaya, S. G. Rhee, L. Oberley, and M. S. Williams. 2002. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 195: 59-70.
15. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735-744.
16. Hildeman, D. A., T. Mitchell, J. Kappler, and P. Marrack. 2003. T cell apoptosis and reactive oxygen species. J. Clin. Invest. 111: 575-581.
17. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131: 2445-2451.
18. Sarmiento, M., A. L. Glasebrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125: 2665-2672.
19. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84: 1374-1378.
20. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149: 380-388.
21. Bakkenist, C. J., and M. B. Kastan. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499-506.
22. Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59: 4375-4382.
23. Kaufmann, W. K., T. P. Heffernan, L. M. Beaulieu, S. Doherty, A. R. Frank, Y. Zhou, M. F. Bryant, T. Zhou, D. D. Luche, N. Nikolaishvili-Feinberg, et al. 2003. Caffeine and human DNA metabolism: the magic and the mystery. Mutat. Res. 532: 85-102.
24. Hickson, I., Y. Zhao, C. J. Richardson, S. J. Green, N. M. Martin, A. I. Orr, P. M. Reaper, S. P. Jackson, N. J. Curtin, and G. C. Smith. 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64: 9152-9159.
25. Hammond, E. M., M. J. Dorie, and A. J. Giaccia. 2003. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 278: 12207-12213.
26. Buscemi, G., P. Perego, N. Carenini, M. Nakanishi, L. Chessa, J. Chen, K. Khanna, and D. Delia. 2004. Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 23: 7691-7700.
27. Kamsler, A., D. Daily, A. Hochman, N. Stern, Y. Shiloh, G. Rotman, and A. Barzilai. 2001. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61: 1849-1854.
28. Reliene, R., E. Fischer, and R. H. Schiestl. 2004. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res. 64: 5148-5153.
29. Pongracz, J., S. Parnell, G. Anderson, J. P. Jaffrezou, and E. Jenkinson. 2003. Con A activates an Akt/PKB dependent survival mechanism to modulate TCR induced cell death in double positive thymocytes. Mol. Immunol. 39: 1013-1023.
30. Block, W. D., D. Merkle, K. Meek, and S. P. Lees-Miller. 2004. Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine. Nucleic Acids Res. 32: 1967-1972.
31. Cortez, D. 2003. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases. J. Biol. Chem. 278: 37139-37145.
32. Golding, S. E., E. Rosenberg, A. Khalil, A. McEwen, M. Holmes, S. Neill, L. F. Povirk, and K. Valerie. 2004. Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J. Biol. Chem. 279: 15402-15410.
33. Choi, E. K., I. M. Ji, S. R. Lee, Y. H. Kook, R. J. Griffin, B. U. Lim, J. S. Kim, D. S. Lee, C. W. Song, and H. J. Park. 2006. Radiosensitization of tumor cells by modulation of ATM kinase. Int. J. Radiat. Biol. 82: 277-283.
34. Kurose, A., T. Tanaka, X. Huang, H. D. Halicka, F. Traganos, W. Dai, and Z. Darzynkiewicz. 2005. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis. Cytometry A 68: 1-9.
35. 2 checkpoint under endogenous or radio-induced DNA damage. Biol. Res. 38: 179-185.
36. McLaughlin, L. M., and B. Demple. 2005. Nitric oxide-induced apoptosis in lymphoblastoid and fibroblast cells dependent on the phosphorylation and activation of p53. Cancer Res. 65: 6097-6104.
37. Nunnari, G., E. Argyris, J. Fang, K. E. Mehlman, R. J. Pomerantz, and R. Daniel. 2005. Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines. Virology 335: 177-184.
38. Petersen, P., D. M. Chou, Z. You, T. Hunter, J. C. Walter, and G. Walter. 2006. Protein phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-independent DNA damage checkpoint. Mol. Cell. Biol. 26: 1997-2011.
39. Wang, H., M. Wang, H. Wang, W, Bocker, and G. Iliakis. 2005. Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors. J. Cell. Physiol. 202: 492-502.
40. Bird, J. J., D. R. Brown, A. C. Mullen, N. H. Moskowitz, M. A. Mahowald, J. R. Sider, T. F. Gajewski, C. R. Wang, and S. L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9: 229-237.